Candidemia due to uncommon Candida species in children: new threat and impacts on outcomes
Open Access
- 15 October 2018
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 8 (1) , 15239
Abstract
Many uncommon Candida spp. (species other than C. albicans, C. parapsilosis, C. glabrata, C. tropicalis, and C. krusei) have been shown to emerge in tertiary care facilities. We aimed to investigate these uncommon candidemia in children. Forty-six cases of candidemia caused by uncommon Candida spp. were identified during 2003–2015 from a medical center in Taiwan. The most common specie was C. guilliermondii (31.2%), followed by C. lusitaniae (18.8%) and C. metapsilosis (18.8%). These cases were analyzed and compared with 148 episodes of C. albicans candidemia. The incidence density of uncommon Candida spp. candidemia and the proportion to all candidemia episodes increased substantively during the study period. Prior exposure to azoles was uncommon in the 30 days prior to infection, but fluconazole resistant strains were significantly more common (n = 19, 41.3%). The increased incidence density of uncommon Candida spp. candidemia was associated with increasing use of antifungal agents. No differences in demographics, underlying comorbidities, risk factors, clinical features, dissemination, and 30-day mortality were found between uncommon Candida spp. and C. albicans candidemia. Patients with uncommon Candida spp. candidemia were more likely to require modifications in antifungal treatment and receive echinocandin drugs (43.5% vs 21.6%, p = 0.007). Candidemia caused by uncommon Candida spp. had poorer response to antifungal treatment, led to longer duration of candidemia (median 4.0 versus 2.5 days, p = 0.008), and had a higher treatment failure rate (56.5% vs 38.5%, p = 0.040).Keywords
Funding Information
- Chang Gung Memorial Hospital, Linkou (CMRPG3E1491)
- Ministry of Health and Welfare (MOHW106-TDU-B-212-113005)
This publication has 50 references indexed in Scilit:
- Results From a Prospective, International, Epidemiologic Study of Invasive Candidiasis in Children and NeonatesThe Pediatric Infectious Disease Journal, 2012
- Progress in Antifungal Susceptibility Testing of Candida spp. by Use of Clinical and Laboratory Standards Institute Broth Microdilution Methods, 2010 to 2012Journal of Clinical Microbiology, 2012
- Epidemiology, Risk Factors and Outcome of Candida parapsilosis Bloodstream Infection in ChildrenThe Pediatric Infectious Disease Journal, 2012
- Performance of Candida Real-time Polymerase Chain Reaction, -D-Glucan Assay, and Blood Cultures in the Diagnosis of Invasive CandidiasisClinical Infectious Diseases, 2012
- Epidemiology and Antifungal Susceptibility of Bloodstream Fungal Isolates in Pediatric Patients: a Spanish Multicenter Prospective SurveyJournal of Clinical Microbiology, 2011
- Candidaemia with uncommon Candida species: predisposing factors, outcome, antifungal susceptibility, and implications for managementClinical Microbiology and Infection, 2009
- Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus CriteriaClinical Infectious Diseases, 2008
- Lodderomyces elongisporus Masquerading as Candida parapsilosis as a Cause of Bloodstream InfectionsJournal of Clinical Microbiology, 2008
- Outbreak of Fungemia among Neonates Caused by Candida haemulonii Resistant to Amphotericin B, Itraconazole, and FluconazoleJournal of Clinical Microbiology, 2007
- Comparative Evaluation of Etest and Sensititre YeastOne Panels against the Clinical and Laboratory Standards Institute M27-A2 Reference Broth Microdilution Method for Testing Candida Susceptibility to Seven Antifungal AgentsJournal of Clinical Microbiology, 2007